Discovery of a novel B-cell lymphoma 6 (BCL6)–corepressor interaction inhibitor by utilizing structure-based drug design

Yasui, Takeshi; Yamamoto, Takeshi; Sakai, Nozomu; Asano, Kouhei; Takai, Takafumi; Yoshitomi, Yayoi; Davis, Melinda; Takagi, Terufumi; Sakamoto, Kotaro; Sogabe, Satoshi; Kamada, Yusuke; Lane, Weston; Snell, Gyorgy; Iwata, Masashi; Goto, Masayuki; Inooka, Hiroshi; Sakamoto, Jun-ichi; Nakada, Yoshihisa; Imaeda, Yasuhiro

doi:10.1016/j.bmc.2017.07.037

Title: Discovery of a novel B-cell lymphoma 6 (BCL6)–corepressor interaction inhibitor by utilizing structure-based drug design

Journal Article · Fri Sep 01 00:00:00 UTC 2017 · Bioorganic and Medicinal Chemistry

DOI: https://doi.org/10.1016/j.bmc.2017.07.037 · OSTI ID:1549649

; Yamamoto, Takeshi; Sakai, Nozomu; Asano, Kouhei;

;

; Davis, Melinda; Takagi, Terufumi; Sakamoto, Kotaro; Sogabe, Satoshi; Kamada, Yusuke; Lane, Weston; Snell, Gyorgy; Iwata, Masashi; Goto, Masayuki; Inooka, Hiroshi; Sakamoto, Jun-ichi; Nakada, Yoshihisa; Imaeda, Yasuhiro

Not Available

View Accepted Manuscript (Publisher)

Cite

Export

Save

Sponsoring Organization:: USDOE Office of Science (SC), Basic Energy Sciences (BES)

Grant/Contract Number:: AC02-05CH11231

OSTI ID:: 1549649

Journal Information:: Bioorganic and Medicinal Chemistry, Journal Name: Bioorganic and Medicinal Chemistry Journal Issue: 17 Vol. 25; ISSN 0968-0896

Publisher:: ElsevierCopyright Statement

Country of Publication:: United Kingdom

Language:: English

References (30)

Small-molecule protein-protein interaction inhibitors: Therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations Buchwald, Peter IUBMB Life, Vol. 62, Issue 10 https://doi.org/10.1002/iub.383	journal	October 2010
Signals that influence T follicular helper cell differentiation and function Linterman, Michelle A.; Vinuesa, Carola G. Seminars in Immunopathology, Vol. 32, Issue 2 https://doi.org/10.1007/s00281-009-0194-z	journal	January 2010
Mechanism of SMRT Corepressor Recruitment by the BCL6 BTB Domain Ahmad, K. Farid; Melnick, Ari; Lax, Stuart Molecular Cell, Vol. 12, Issue 6 https://doi.org/10.1016/S1097-2765(03)00454-4	journal	December 2003
Discovery of high-affinity BCL6-binding peptide and its structure-activity relationship Sakamoto, Kotaro; Sogabe, Satoshi; Kamada, Yusuke Biochemical and Biophysical Research Communications, Vol. 482, Issue 2 https://doi.org/10.1016/j.bbrc.2016.11.060	journal	January 2017
A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In Vivo Cerchietti, Leandro C.; Ghetu, Alexandru F.; Zhu, Xiao Cancer Cell, Vol. 17, Issue 4 https://doi.org/10.1016/j.ccr.2009.12.050	journal	April 2010
Predicting druggable binding sites at the protein–protein interface Fuller, Jonathan C.; Burgoyne, Nicholas J.; Jackson, Richard M. Drug Discovery Today, Vol. 14, Issue 3-4 https://doi.org/10.1016/j.drudis.2008.10.009	journal	February 2009
RNA interference targeting Bcl-6 ameliorates experimental autoimmune myasthenia gravis in mice Xin, Ning; Fu, Linlin; Shao, Zhen Molecular and Cellular Neuroscience, Vol. 58 https://doi.org/10.1016/j.mcn.2013.12.006	journal	January 2014
Structure of a BCOR Corepressor Peptide in Complex with the BCL6 BTB Domain Dimer Ghetu, Alexandru F.; Corcoran, Connie M.; Cerchietti, Leandro Molecular Cell, Vol. 29, Issue 3 https://doi.org/10.1016/j.molcel.2007.12.026	journal	February 2008
Discovery of a B-Cell Lymphoma 6 Protein–Protein Interaction Inhibitor by a Biophysics-Driven Fragment-Based Approach Kamada, Yusuke; Sakai, Nozomu; Sogabe, Satoshi Journal of Medicinal Chemistry, Vol. 60, Issue 10 https://doi.org/10.1021/acs.jmedchem.7b00313	journal	May 2017
Discovery of Pyrazolo[1,5- a ]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors McCoull, William; Abrams, Roman D.; Anderson, Erica Journal of Medicinal Chemistry, Vol. 60, Issue 10 https://doi.org/10.1021/acs.jmedchem.7b00359	journal	May 2017
The solvatochromic comparison method. 3. Hydrogen bonding by some 2-nitroaniline derivatives Yokoyama, Tai; Taft, R. W.; Kamlet, Mortimer J. Journal of the American Chemical Society, Vol. 98, Issue 11 https://doi.org/10.1021/ja00427a030	journal	May 1976
Improvement in Aqueous Solubility in Small Molecule Drug Discovery Programs by Disruption of Molecular Planarity and Symmetry Ishikawa, Minoru; Hashimoto, Yuichi Journal of Medicinal Chemistry, Vol. 54, Issue 6 https://doi.org/10.1021/jm101356p	journal	March 2011
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces Wells, James A.; McClendon, Christopher L. Nature, Vol. 450, Issue 7172 https://doi.org/10.1038/nature06526	journal	December 2007
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition Duy, Cihangir; Hurtz, Christian; Shojaee, Seyedmehdi Nature, Vol. 473, Issue 7347 https://doi.org/10.1038/nature09883	journal	May 2011
The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT Huynh, Khanh D.; Bardwell, Vivian J. Oncogene, Vol. 17, Issue 19 https://doi.org/10.1038/sj.onc.1202197	journal	October 1998
Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas Parekh, Samir; Privé, Gilbert; Melnick, Ari Leukemia & Lymphoma, Vol. 49, Issue 5 https://doi.org/10.1080/10428190801895345	journal	January 2008
BCoR, a novel corepressor involved in BCL-6 repression Huynh, Khanh D.; Fischle, Wolfgang; Verdin, Eric Genes & Development, Vol. 14, Issue 14 https://doi.org/10.1101/gad.14.14.1810	journal	July 2000
MOLREP an Automated Program for Molecular Replacement Vagin, A.; Teplyakov, A. Journal of Applied Crystallography, Vol. 30, Issue 6, p. 1022-1025 https://doi.org/10.1107/S0021889897006766	journal	December 1997
MolProbity : all-atom structure validation for macromolecular crystallography Chen, Vincent B.; Arendall, W. Bryan; Headd, Jeffrey J. Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 1 https://doi.org/10.1107/S0907444909042073	journal	December 2009
Features and development of Coot Emsley, P.; Lohkamp, B.; Scott, W. G. Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4 https://doi.org/10.1107/S0907444910007493	journal	March 2010
REFMAC 5 for the refinement of macromolecular crystal structures Murshudov, Garib N.; Skubák, Pavol; Lebedev, Andrey A. Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4 https://doi.org/10.1107/S0907444911001314	journal	March 2011
The CCP4 suite programs for protein crystallography Acta Crystallographica Section D Biological Crystallography, Vol. 50, Issue 5, p. 760-763 https://doi.org/10.1107/S0907444994003112	journal	September 1994
Roles of BCL6 in normal and transformed germinal center B cells: BCL6 role in GC B cells Basso, Katia; Dalla-Favera, Riccardo Immunological Reviews, Vol. 247, Issue 1 https://doi.org/10.1111/j.1600-065X.2012.01112.x	journal	April 2012
Control of Inflammation, Cytokine Expression, and Germinal Center Formation by BCL-6 Dent, A. L. Science, Vol. 276, Issue 5312 https://doi.org/10.1126/science.276.5312.589	journal	April 1997
Critical Residues within the BTB Domain of PLZF and Bcl-6 Modulate Interaction with Corepressors Melnick, Ari; Carlile, Graeme; Ahmad, K. Farid Molecular and Cellular Biology, Vol. 22, Issue 6 https://doi.org/10.1128/MCB.22.6.1804-1818.2002	journal	March 2002
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma Cardenas, Mariano G.; Yu, Wenbo; Beguelin, Wendy Journal of Clinical Investigation, Vol. 126, Issue 9 https://doi.org/10.1172/JCI85795	journal	August 2016
BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms Parekh, Samir; Polo, Jose M.; Shaknovich, Rita Blood, Vol. 110, Issue 6 https://doi.org/10.1182/blood-2007-01-069575	journal	September 2007
A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo Cerchietti, Leandro C.; Yang, Shao Ning; Shaknovich, Rita Blood, Vol. 113, Issue 15 https://doi.org/10.1182/blood-2008-07-168773	journal	April 2009
BCL-6 protein is expressed in germinal-center B cells Cattoretti, G.; Chang, Cc; Cechova, K. Blood, Vol. 86, Issue 1 https://doi.org/10.1182/blood.V86.1.45.bloodjournal86145	journal	July 1995
The Ansamycin Antibiotic, Rifamycin SV, Inhibits BCL6 Transcriptional Repression and Forms a Complex with the BCL6-BTB/POZ Domain Evans, Sian E.; Goult, Benjamin T.; Fairall, Louise PLoS ONE, Vol. 9, Issue 3 https://doi.org/10.1371/journal.pone.0090889	journal	March 2014

Similar Records

Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design—Part 2

Journal Article · Wed Jun 01 00:00:00 UTC 2016 · Bioorganic and Medicinal Chemistry Letters · OSTI ID:1358849

McBride, Christopher; Cheruvallath, Zacharia; Komandla, Mallareddy; +9 more

Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6

Journal Article · Wed Oct 17 00:00:00 UTC 2018 · ACS Chemical Biology · OSTI ID:1544823

McCoull, William; Cheung, Tony; Anderson, Erica; +34 more

Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors

Journal Article · Tue May 09 04:00:00 UTC 2017 · Journal of Medicinal Chemistry · OSTI ID:1510231

McCoull, William; Abrams, Roman D.; Anderson, Erica; +31 more

Title: Discovery of a novel B-cell lymphoma 6 (BCL6)–corepressor interaction inhibitor by utilizing structure-based drug design

Citation Formats

References (30)

Similar Records

Related Subjects